Document is current
Any future updates will be listed below
-
Authors
Ciet, Pierluigi https://orcid.org/0000-0003-4017-8957
Booij, Ronald
Dijkshoorn, Marcel
van Straten, Marcel
Tiddens, Harm A. W. M.
- License Information
-
More Information
Article History
Received: 4 May 2022
Revised: 1 August 2022
Accepted: 22 September 2022
First Online: 29 October 2022
Declarations
:
: Author Pierluigi Ciet reports grants from the American and Italian Cystic Fibrosis Foundations and from the Dutch Research Council. Moreover, the author received a consultancy fee from Vertex Pharmaceutical and Chiesi that was unrelated to the submitted work. Author Harm A.W.M. Tiddens reports grants from the Cystic Fibrosis Foundation and Health Holland, is director of the Erasmus MC–Lung Analysis laboratory, which also acts as the European Cystic Fibrosis Society Clinical Trial Network (ECFS-CTN) and Computed Tomography (CT) expert centre and serves as chief medical officer for the company Thirona B.V., Nijmegen, the Netherlands. Erasmus MC is expected to receive future license royalties for PRAGMA-CF (Perth-Rotterdam Annotated Grid Morphometric Analysis for CF). Ronald Booij, Marcel Dijkshoorn and Marcel van Straten have nothing to disclose.
